Interestingly, treatment of Foxp1± mice with the PDE10A antagonist MP‐10 (PF‐2545920) immediately after birth not only corrects behavioral abnormalities, including decreased ultrasonic vocalization, hyperactivity, and anxiety but also normalizes changes in microglia morphology and synaptic pruning. The gene discussed is PDE10A; the disease is Anxiety.